Registration No. 333-137756
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Post-Effective Amendment No. 1
to
FORM S-3
REGISTRATION STATEMENT
UNDER THE
SECURITIES ACT OF 1933
MedCath Corporation
(Exact name of Registrant as specified in its Charter)
| Delaware | 56-2248952 | |
(State or other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |
10720 Sikes Place, Suite 200 Charlotte, North Carolina | 28277 | |
| (Address of principal executive offices) | (Zip Code) | |
James A. Parker
President and Chief Executive Officer
MedCath Corporation
10720 Sikes Place, Suite 200
Charlotte, North Carolina 28277
(Name and Address of Agent for Service)
(704) 815-7700
(Telephone number, Including Area Code, of Agent for Service)
Copy to:
Hal Levinson
Moore & Van Allen PLLC
100 North Tryon Street, Suite 4700
Charlotte, North Carolina 28202-4003
(704) 331-1050
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
| Large accelerated filer | ¨ | Accelerated filer | x | |||
| Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ | |||
EXPLANATORY NOTE
This Post-Effective Amendment No. 1 (the “Post-Effective Amendment”) to Registration Statement on Form S-3, No. 333-137756 (the “Registration Statement”) of MedCath Corporation (the “Company” or the “Registrant”) is being filed to terminate the effectiveness of the Registration Statement and to deregister 2,000,000 shares that were registered under the Registration Statement for sale by certain selling stockholders in a public offering through a group of underwriters and were unsold at the termination of the offering.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Charlotte, State of North Carolina, on August 28, 2012.
| MEDCATH CORPORATION | ||
| By: | /s/ James A. Parker | |
| James A. Parker | ||
| President and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities indicated on the dates indicated.
Signature | Title | Date | ||
/s/ James A Parker James A. Parker | President, Chief Executive Officer and Director (Principal Executive Officer) | August 28, 2012 | ||
/s/ Lora Ramsey Lora Ramsey | Vice President and Chief Financial Officer (Principal Financial Officer) | August 28, 2012 | ||
/s/ Woodrin Grossman Woodrin Grossman | Director | August 28, 2012 | ||
/s/ John T. Casey John T. Casey | Director | August 28, 2012 | ||
/s/ Jacque J. Sokolov Jacque J. Sokolov, Md | Director | August 28, 2012 | ||
/s/ Pamela G. Bailey Pamela G. Bailey | Director | August 28, 2012 | ||
/s/ Robert S. McCoy, Jr. Robert S. McCoy, Jr. | Director | August 28, 2012 | ||
/s/ James A. Deal James A. Deal | Director | August 28, 2012 | ||
